Pharmaceutical news | ELSI Avocats

Filter by

Pharmaceutical law

What are the new rules applicable to health influencers?

Since June 10, 2023, influencer activity has been subject to its own regulations. Here's a look at its impact on healthcare.

Medical device law

Publication of the ONCD's report on the application of the Benefits Framework Act (LEA)

A look back at the CNOCD's report on the state of its anti-gift law enforcement practices

Medical device law

Coverage and reimbursement of Class A and B optical lenses and equipment - How to market them?

Coverage and access to reimbursement of optical equipment: registration in the LPPR deciphered

Digital & E-health

RGPD - Violation of the RGPD does not in itself give rise to a right to compensation

Contributions of the April and May 2023 rulings of the CAA of Paris and the CJEU on the conditions for redress in case of breach of the GDPR.

Pharmaceutical law

Amiodarone, the Court of Cassation sanctions the lack of information in the package insert and engages the responsibility of the laboratory

Liability: the Cour de cassation confirms the lack of information based on the inadequacy of the information contained in the SPCs and leaflets

Pharmaceutical law

Law on the supervision of benefits, the CNOM publishes its evaluation report

Review of the CNOM's report on the state of its practice in terms of monitoring the application of the anti-gift law

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Newsletter subscription

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

NEWS

Cosmetics regulations: how to ensure safe marketing?

What are the new rules applicable to health influencers?

Publication of the ONCD's report on the application of the Benefits Framework Act (LEA)

Coverage and reimbursement of Class A and B optical lenses and equipment - How to market them?

RGPD - Violation of the RGPD does not in itself give rise to a right to compensation

Amiodarone, the Court of Cassation sanctions the lack of information in the package insert and engages the responsibility of the laboratory

Law on the supervision of benefits, the CNOM publishes its evaluation report

Amiodarone, the Court of Cassation sanctions the lack of information in the package insert and engages the responsibility of the laboratory

Cannabis: regulation of the marketing of CBD flower before the Constitutional Council

Certificate of free sale and medical devices

Ranking of Life sciences law firms: ELSI Avocats wins 1st place in the Palmarès du Droit 2023

Entry into force of Regulation 2017/745 on medical devices (MDR): update on clinical evaluation

NEWS

Cosmetics regulations: how to ensure safe marketing?

What are the new rules applicable to health influencers?

Publication of the ONCD's report on the application of the Benefits Framework Act (LEA)

Coverage and reimbursement of Class A and B optical lenses and equipment - How to market them?

RGPD - Violation of the RGPD does not in itself give rise to a right to compensation

Amiodarone, the Court of Cassation sanctions the lack of information in the package insert and engages the responsibility of the laboratory

Law on the supervision of benefits, the CNOM publishes its evaluation report

Amiodarone, the Court of Cassation sanctions the lack of information in the package insert and engages the responsibility of the laboratory

Cannabis: regulation of the marketing of CBD flower before the Constitutional Council

Certificate of free sale and medical devices

Ranking of Life sciences law firms: ELSI Avocats wins 1st place in the Palmarès du Droit 2023

Entry into force of Regulation 2017/745 on medical devices (MDR): update on clinical evaluation

SUBSCRIBE TO OUR NEWSLETTER!